Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder

• Published in: Pharmacogenomics and personalized medicine Vol. 10; p. 187
• Main Authors: Brenton, Ashley, Richeimer, Steven, Sharma, Maneesh, Lee, Chee, Kantorovich, Svetlana, Blanchard, John, Meshkin, Brian
• Format: Journal Article
• Language: English
• Published: Dove Medical Press Limited 01.01.2017
• Subjects: Diagnosis; Evaluation; Health status indicators; Identification and classification; Opioid abuse; Single nucleotide polymorphisms
• ISSN: 1178-7066; 1178-7066
• DOI: 10.2147/PGPM.S129908

Background: Opioid abuse in chronic pain patients is a major public health issue, with rapidly increasing addiction rates and deaths from unintentional overdose more than quadrupling since 1999. Purpose: This study seeks to determine the predictability of aberrant behavior to opioids using a comprehensive scoring algorithm incorporating phenotypic risk factors and neuroscience-associated single-nucleotide polymorphisms (SNPs). Patients and methods: The Proove Opioid Risk (POR) algorithm determines the predictability of aberrant behavior to opioids using a comprehensive scoring algorithm incorporating phenotypic risk factors and neuroscience-associated SNPs. In a validation study with 258 subjects with diagnosed opioid use disorder (OUD) and 650 controls who reported using opioids, the POR successfully categorized patients at high and moderate risks of opioid misuse or abuse with 95.7% sensitivity. Regardless of changes in the prevalence of opioid misuse or abuse, the sensitivity of POR remained >95%. Conclusion: The POR correctly stratifies patients into low-, moderate-, and high-risk categories to appropriately identify patients at need for additional guidance, monitoring, or treatment changes. Keywords: opioid use disorder, addiction, personalized medicine, pharmacogenetics, genetic testing, predictive algorithm